Tag: biosimilars

Lot-to-lot variability is a natural part of biologic and biosimilar manufacturing. Unlike generics, biosimilars aren't identical copies - they're highly similar, with controlled variations that don't affect safety or effectiveness. This is how modern biologics work.

Patent expiry means cheaper drugs-but only if patients and healthcare systems plan ahead. Learn what happens when brand-name drugs lose exclusivity, how to navigate switches to generics, and why timing matters more than ever.